Holen Sie sich die Stockscreener-App
7.20
0.83%
-0.06
Handel nachbörslich:
7.20
Schlusskurs vom Vortag:
$7.26
Offen:
$7.19
24-Stunden-Volumen:
2.39M
Relative Volume:
0.32
Marktkapitalisierung:
$1.14B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.2478
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
+5.42%
1M Leistung:
-16.67%
6M Leistung:
-15.99%
1J Leistung:
-45.99%
1-Tages-Spanne:
$7.06
$7.265
1-Wochen-Bereich:
$6.35
$7.365
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.20 | 1.14B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Citi Revises Teladoc (TDOC) Price Target Amidst Cautious Outlook - GuruFocus
To Register Unwavering Growth Of Remote Medical Expert - openPR.com
Teladoc Health (NYSE:TDOC) Shares Fall 10% Over The Past Week - Yahoo Finance
Teladoc (TDOC) Experiences Surge in Bullish Option Activity | TDOC Stock News - GuruFocus
Digital Health In The Neurology Market Focusing On A Series - openPR.com
Chronic Disease Management Market Is Booming So Rapidly - openPR.com
U.S. Digital Mental Health Market New Product Development & Latest Trends | Teladoc Health,BetterHelp,Talkspace - openPR.com
Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? - Insider Monkey
Teladoc Health (TDOC) to Announce Q1 2025 Earnings on April 30 - GuruFocus
10 Best Telehealth Stocks to Buy Now - Insider Monkey
Jefferies cuts Teladoc price target to $8, maintains hold rating By Investing.com - Investing.com India
Jefferies cuts Teladoc price target to $8, maintains hold rating - Investing.com
Teladoc stock plunges to 52-week low, hits $6.61 By Investing.com - Investing.com India
Jefferies Lowers Teladoc (TDOC) Price Target Amid Declining Data Trends | TDOC Stock News - GuruFocus
Teladoc stock plunges to 52-week low, hits $6.61 - Investing.com
Emerging Trends in Telemedicine Second Opinion Solutions - openPR.com
Forecasting the Future: Healthcare Convenience Services - openPR.com
Telehealth Market Size to Reach USD 791.04 billion by 2032, Growing at CAGR of 22.9%NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Telestroke Services Market Set to Witness Significant Growth by 2025-2032 | ScienceSoft, SEVARO, Teladoc Health - openPR.com
Teladoc Health to Announce First Quarter 2025 Financial Results - GuruFocus
Teladoc Health to Announce First Quarter 2025 Financial Results | TDOC Stock News - GuruFocus
Teladoc Health Inc. to Release First Quarter 2025 Results on April 30, 2025 - Nasdaq
Virtual Care Leader Teladoc Health Sets Q1 2025 Earnings Release DateKey Details Inside - Stock Titan
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Emerging Trends in Video Consultation Medical Service Market - openPR.com
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - TradingView
Future Scope of Virtual Healthcare Home Market to Observe - openPR.com
Virtual Care Services Market Projected To Witness Massive - openPR.com
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction - MSN
Teladoc (TDOC) Experiences Increased Option Activity Ahead of Ea - GuruFocus
BofA Revises Teladoc (TDOC) Price Target Amid Weaker Growth and Strategic Initiatives | TDOC Stock News - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
Lobbying Update: $10,000 of TELADOC HEALTH INC. lobbying was just disclosed - Nasdaq
Teladoc Health Launches New Cardiometabolic Health Program - MedCity News
Unparalleled Research on Behavioral Health Telehealth Market - openPR.com
Digital Health Market Projected To Witness Substantial Growth, - openPR.com
Teladoc (TDOC) Stock Moves -0.97%: What You Should Know - Yahoo Finance
Teladoc Health CFO Murthy Mala sells $51,011 in stock By Investing.com - Investing.com South Africa
Teladoc Health CFO Murthy Mala sells $51,011 in stock - Investing.com
Trend Tracker for (TDOC) - news.stocktradersdaily.com
Teladoc unveils virtual care tool for cardiometabolic health - TechTarget
Digital health startup Transcarent takes Accolade private in $621 million deal - CNBC
Teladoc Health Introduces Next Generation Cardiometabolic Health Program - GlobeNewswire
Revolutionary: New Teladoc Health Program Achieves 58% Diabetes Remission Levels - Stock Titan
Teladoc Stock Plummets to 52-Week Low of $6.76 Amid Market Challenges - Investing.com India
Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights – TDOC - ACCESS Newswire
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - AOL.com
Major Player in the Teletherapy Platform Integration Market - openPR.com
Teladoc (TDOC) Gains But Lags Market: What You Should Know - Yahoo Finance
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):